Markers of cognitive function in individuals with metabolic disease: Morquio Syndrome and Tyrosinemia Type III

James Blundell, S. Frisson, Anupam Chakrapani, Shauna Kearney, Suresh Vijay, Anita MacDonald, Paul Gissen, Chris Hendriksz, Andrew Olson

Research output: Contribution to journalArticle

2 Citations (Scopus)
11 Downloads (Pure)

Abstract

We characterise cognitive function in two neurodegenerative metabolic diseases where cognitive effects have been considered mild or non-existent. We asked whether cognitive effects were present and whether the cognitive effects of neurodegeneration were hetero- or homogeneous across diseases. Thirteen Morquio syndrome patients, 11 Tyrosinemia Type III patients and 104 controls were assessed using tasks for attention (simple RT, feature and conjunction visual search), language (BPVS, BNT) and oculomotor function (fixation, pro-saccade, anti-saccade, smooth pursuit). There were different patterns of deficits. In Morquio syndrome, visual search was slow, differences did not increase in proportion to display sizes and were not driven by the longest reaction times in the distirbution. In addition, maintaining gaze on a target in an oculomotor task was difficult. These patterns point to problems with control processes for attention. Language was relatively spared. In Tyrosinemia Type III, in contrast, there were modest effects in attention, but language was clearly affected, and effects increased with age. Both diseases presented clear evidence of cognitive effects, but with different functional profiles. The different markers (attentional control in Morquio and language in Tyrosinemia) are good candidates for disease tracking and for establishing functional/biological links and they suggest that there may be stronger impacts in different regions of the brain (frontal vs temporal areas).
Original languageEnglish
Pages (from-to)120-147
Number of pages28
JournalCognitive Neuropsychology
Volume35
Issue number3-4
Early online date9 May 2018
DOIs
Publication statusPublished - 2018
Externally publishedYes

Fingerprint

Mucopolysaccharidosis IV
Tyrosinemias
Metabolic Diseases
Cognition
Language
Saccades
Smooth Pursuit
Neurodegenerative Diseases
Reaction Time
Cognitive Function
Syndrome
Brain

Bibliographical note

This is an Accepted Manuscript of an article published by Taylor & Francis in Cognitive Neuropsychology on 09/05/2018, available online: http://www.tandfonline.com/10.1080/02643294.2018.1443913

Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

Keywords

  • attention
  • developmental disorders
  • language
  • morquio
  • tyrosinemia

Cite this

Markers of cognitive function in individuals with metabolic disease: Morquio Syndrome and Tyrosinemia Type III. / Blundell, James; Frisson, S.; Chakrapani, Anupam; Kearney, Shauna; Vijay, Suresh; MacDonald, Anita; Gissen, Paul; Hendriksz, Chris; Olson, Andrew.

In: Cognitive Neuropsychology, Vol. 35, No. 3-4, 2018, p. 120-147.

Research output: Contribution to journalArticle

Blundell, J, Frisson, S, Chakrapani, A, Kearney, S, Vijay, S, MacDonald, A, Gissen, P, Hendriksz, C & Olson, A 2018, 'Markers of cognitive function in individuals with metabolic disease: Morquio Syndrome and Tyrosinemia Type III' Cognitive Neuropsychology, vol. 35, no. 3-4, pp. 120-147. https://doi.org/10.1080/02643294.2018.1443913
Blundell, James ; Frisson, S. ; Chakrapani, Anupam ; Kearney, Shauna ; Vijay, Suresh ; MacDonald, Anita ; Gissen, Paul ; Hendriksz, Chris ; Olson, Andrew. / Markers of cognitive function in individuals with metabolic disease: Morquio Syndrome and Tyrosinemia Type III. In: Cognitive Neuropsychology. 2018 ; Vol. 35, No. 3-4. pp. 120-147.
@article{cc467129c5594638bb816b2e14b4790c,
title = "Markers of cognitive function in individuals with metabolic disease: Morquio Syndrome and Tyrosinemia Type III",
abstract = "We characterise cognitive function in two neurodegenerative metabolic diseases where cognitive effects have been considered mild or non-existent. We asked whether cognitive effects were present and whether the cognitive effects of neurodegeneration were hetero- or homogeneous across diseases. Thirteen Morquio syndrome patients, 11 Tyrosinemia Type III patients and 104 controls were assessed using tasks for attention (simple RT, feature and conjunction visual search), language (BPVS, BNT) and oculomotor function (fixation, pro-saccade, anti-saccade, smooth pursuit). There were different patterns of deficits. In Morquio syndrome, visual search was slow, differences did not increase in proportion to display sizes and were not driven by the longest reaction times in the distirbution. In addition, maintaining gaze on a target in an oculomotor task was difficult. These patterns point to problems with control processes for attention. Language was relatively spared. In Tyrosinemia Type III, in contrast, there were modest effects in attention, but language was clearly affected, and effects increased with age. Both diseases presented clear evidence of cognitive effects, but with different functional profiles. The different markers (attentional control in Morquio and language in Tyrosinemia) are good candidates for disease tracking and for establishing functional/biological links and they suggest that there may be stronger impacts in different regions of the brain (frontal vs temporal areas).",
keywords = "attention, developmental disorders, language, morquio, tyrosinemia",
author = "James Blundell and S. Frisson and Anupam Chakrapani and Shauna Kearney and Suresh Vijay and Anita MacDonald and Paul Gissen and Chris Hendriksz and Andrew Olson",
note = "This is an Accepted Manuscript of an article published by Taylor & Francis in Cognitive Neuropsychology on 09/05/2018, available online: http://www.tandfonline.com/10.1080/02643294.2018.1443913 Copyright {\circledC} and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.",
year = "2018",
doi = "10.1080/02643294.2018.1443913",
language = "English",
volume = "35",
pages = "120--147",
journal = "Cognitive Neuropsychology",
issn = "0264-3294",
publisher = "Taylor and Francis Ltd.",
number = "3-4",

}

TY - JOUR

T1 - Markers of cognitive function in individuals with metabolic disease: Morquio Syndrome and Tyrosinemia Type III

AU - Blundell, James

AU - Frisson, S.

AU - Chakrapani, Anupam

AU - Kearney, Shauna

AU - Vijay, Suresh

AU - MacDonald, Anita

AU - Gissen, Paul

AU - Hendriksz, Chris

AU - Olson, Andrew

N1 - This is an Accepted Manuscript of an article published by Taylor & Francis in Cognitive Neuropsychology on 09/05/2018, available online: http://www.tandfonline.com/10.1080/02643294.2018.1443913 Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

PY - 2018

Y1 - 2018

N2 - We characterise cognitive function in two neurodegenerative metabolic diseases where cognitive effects have been considered mild or non-existent. We asked whether cognitive effects were present and whether the cognitive effects of neurodegeneration were hetero- or homogeneous across diseases. Thirteen Morquio syndrome patients, 11 Tyrosinemia Type III patients and 104 controls were assessed using tasks for attention (simple RT, feature and conjunction visual search), language (BPVS, BNT) and oculomotor function (fixation, pro-saccade, anti-saccade, smooth pursuit). There were different patterns of deficits. In Morquio syndrome, visual search was slow, differences did not increase in proportion to display sizes and were not driven by the longest reaction times in the distirbution. In addition, maintaining gaze on a target in an oculomotor task was difficult. These patterns point to problems with control processes for attention. Language was relatively spared. In Tyrosinemia Type III, in contrast, there were modest effects in attention, but language was clearly affected, and effects increased with age. Both diseases presented clear evidence of cognitive effects, but with different functional profiles. The different markers (attentional control in Morquio and language in Tyrosinemia) are good candidates for disease tracking and for establishing functional/biological links and they suggest that there may be stronger impacts in different regions of the brain (frontal vs temporal areas).

AB - We characterise cognitive function in two neurodegenerative metabolic diseases where cognitive effects have been considered mild or non-existent. We asked whether cognitive effects were present and whether the cognitive effects of neurodegeneration were hetero- or homogeneous across diseases. Thirteen Morquio syndrome patients, 11 Tyrosinemia Type III patients and 104 controls were assessed using tasks for attention (simple RT, feature and conjunction visual search), language (BPVS, BNT) and oculomotor function (fixation, pro-saccade, anti-saccade, smooth pursuit). There were different patterns of deficits. In Morquio syndrome, visual search was slow, differences did not increase in proportion to display sizes and were not driven by the longest reaction times in the distirbution. In addition, maintaining gaze on a target in an oculomotor task was difficult. These patterns point to problems with control processes for attention. Language was relatively spared. In Tyrosinemia Type III, in contrast, there were modest effects in attention, but language was clearly affected, and effects increased with age. Both diseases presented clear evidence of cognitive effects, but with different functional profiles. The different markers (attentional control in Morquio and language in Tyrosinemia) are good candidates for disease tracking and for establishing functional/biological links and they suggest that there may be stronger impacts in different regions of the brain (frontal vs temporal areas).

KW - attention

KW - developmental disorders

KW - language

KW - morquio

KW - tyrosinemia

U2 - 10.1080/02643294.2018.1443913

DO - 10.1080/02643294.2018.1443913

M3 - Article

VL - 35

SP - 120

EP - 147

JO - Cognitive Neuropsychology

JF - Cognitive Neuropsychology

SN - 0264-3294

IS - 3-4

ER -